Global Follicle Stimulating Hormone Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Follicle Stimulating Hormone Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Follicle stimulating hormone (FSH) is a hormone made by the pituitary gland that affects the gonads (female ovaries and males testes). In females, it stimulates growth of the ovarian follicles.
Follicle Stimulating Hormone report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Follicle Stimulating Hormone market is projected to reach US$ 1550.6 million in 2034, increasing from US$ 1275.1 million in 2022, with the CAGR of 2.8% during the period of 2024 to 2034. Demand from Infertility Treatment and Assisted Reproductive Technology are the major drivers for the industry.
Due to less pollution, recombinant FSH takes large proportion in market. In 2019, recombinant FSH takes about 82% of Poland follicle stimulating hormone consumption market share.
There are only several companies producing this product, such as Merck Serono, MSD, IBSA, Ferring, Livzon and Techwell etc. Merck Serono and MSD are Top 2 companies in the world. In 2019, Merck Serono takes about 55% of Poland follicle stimulating hormone revenue. MSD takes about 18% of Poland follicle stimulating hormone revenue.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Follicle Stimulating Hormone market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
Merck Serono
MSD
IBSA
Ferring
Livzon
Techwell
GenSci
Gedeon Richter
Teva
Segment by Type
Recombinant FSH
Urinary FSH
Infertility Treatment
Assisted Reproductive Technology
North America
Europe
Poland
Asia-Pacific
Latin America
Middle East & Africa
Each chapter of the report provides detailed information for readers to understand the Follicle Stimulating Hormone market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Follicle Stimulating Hormone, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Follicle Stimulating Hormone industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Follicle Stimulating Hormone in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Follicle Stimulating Hormone introduction, etc. Follicle Stimulating Hormone Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13QYResearch’s Conclusions of Follicle Stimulating Hormone market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by QYResearch.
Follicle Stimulating Hormone report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Follicle Stimulating Hormone market is projected to reach US$ 1550.6 million in 2034, increasing from US$ 1275.1 million in 2022, with the CAGR of 2.8% during the period of 2024 to 2034. Demand from Infertility Treatment and Assisted Reproductive Technology are the major drivers for the industry.
Due to less pollution, recombinant FSH takes large proportion in market. In 2019, recombinant FSH takes about 82% of Poland follicle stimulating hormone consumption market share.
There are only several companies producing this product, such as Merck Serono, MSD, IBSA, Ferring, Livzon and Techwell etc. Merck Serono and MSD are Top 2 companies in the world. In 2019, Merck Serono takes about 55% of Poland follicle stimulating hormone revenue. MSD takes about 18% of Poland follicle stimulating hormone revenue.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Follicle Stimulating Hormone market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
By Company
Merck Serono
MSD
IBSA
Ferring
Livzon
Techwell
GenSci
Gedeon Richter
Teva
Segment by Type
Recombinant FSH
Urinary FSH
Segment by Application
Infertility Treatment
Assisted Reproductive Technology
Segment by Region
North America
Europe
Poland
Asia-Pacific
Latin America
Middle East & Africa
Each chapter of the report provides detailed information for readers to understand the Follicle Stimulating Hormone market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Follicle Stimulating Hormone, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Follicle Stimulating Hormone industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Follicle Stimulating Hormone in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Follicle Stimulating Hormone introduction, etc. Follicle Stimulating Hormone Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13QYResearch’s Conclusions of Follicle Stimulating Hormone market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by QYResearch.
Electronic and Semiconductor
Food and Beverages
Chemicals and Materials
Consumer Goods
Construction Manufacturing
Aerospace and Defence
Energy and Power
ICT Media
Banking and Finance
Automotive and Transportation
Machinery and Equipments
Pharmaceutical and Healthcare
Medical Devices